On Tuesday, Cathie Wood-led Ark Invest made a notable decision by selling shares of Tempus AI Inc. TEM, marking a significant move in their investment strategy. The Tempus AI TradeArk Invest sold 62,352 shares of Tempus AI (Pre-Reincorporation) through the ARK Innovation ETF ARKK. This move comes after Tempus AI recently received FDA 510(k) clearance for its RNA-based Tempus xR IVD device, a significant milestone that had previously driven the stock higher. On September 18, Ark sold 43,157 shares of Tempus AI. Benzinga's Edge Stock Rankings indicate Tempus AI stock checks out on Short, Medium and Long Price trends.